Number of Participants With Biopsy-detectable Prostate Cancer at Years 2 and 4 (Crude Rate Approach) Years 1-2, Years 3-4, and Overall (Years 1-4) [clinicaltrials_resource:d048eae4328b4a5c3540f1b95f1f29ac]
Study biopsies consisted of 10 biopsy samples (cores) in a pre-defined pattern. Biopsies were read at the central pathology laboratory (CPL, which processed the majority, 94%, of biopsies). Biopsy cases that were positive for prostate cancer or precancerous lesions (high-grade prostatic intraepithelial neoplasia[HGPIN] or typical small acinar proliferation [ASAP]) and prostate surgeries were reviewed by the lead pathologist.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Number of Participants With Biopsy-detectable Prostate Cancer at Years 2 and 4 (Crude Rate Approach) Years 1-2, Years 3-4, and Overall (Years 1-4) [clinicaltrials_resource:d048eae4328b4a5c3540f1b95f1f29ac]
Study biopsies consisted of 10 biopsy samples (cores) in a pre-defined pattern. Biopsies were read at the central pathology laboratory (CPL, which processed the majority, 94%, of biopsies). Biopsy cases that were positive for prostate cancer or precancerous lesions (high-grade prostatic intraepithelial neoplasia[HGPIN] or typical small acinar proliferation [ASAP]) and prostate surgeries were reviewed by the lead pathologist.
Bio2RDF identifier
d048eae4328b4a5c3540f1b95f1f29ac
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d048eae4328b4a5c3540f1b95f1f29ac
measure [clinicaltrials_vocabulary:measure]
Number of Participants With Bi ...... 2 and 4 (Crude Rate Approach)
time frame [clinicaltrials_vocabulary:time-frame]
Years 1-2, Years 3-4, and Overall (Years 1-4)
description
Study biopsies consisted of 10 ...... iewed by the lead pathologist.
identifier
clinicaltrials_resource:d048eae4328b4a5c3540f1b95f1f29ac
title
Number of Participants With Bi ...... s 3-4, and Overall (Years 1-4)
@en
type
label
Number of Participants With Bi ...... 8eae4328b4a5c3540f1b95f1f29ac]
@en